ArticleNeurobiology of disease2016

In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin.

Matteo Santoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.